The Pharmacogenomics Journal - Table of Contents alert Volume 18 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 18, Issue 2 (March 2018) In this issue Review Consensus Article Original Articles Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe Review   Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes G S Hwang, R Bhat, R D Crutchley and M V Trivedi Pharmacogenomics J 2018 18: 201-208; advance online publication, August 1, 2017; 10.1038/tpj.2017.36 Abstract | Full Text Consensus Article   Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease N J Butcher, M K Horne, G D Mellick, C J Fowler, C L Masters, AIBL research group and R F Minchin Pharmacogenomics J 2018 18: 209-214; advance online publication, April 4, 2017; 10.1038/tpj.2017.4 Abstract | Full Text Original Articles   Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology A A Seyerle, C M Sitlani, R Noordam, S M Gogarten, J Li, X Li, D S Evans, F Sun, M A Laaksonen, A Isaacs, K Kristiansson, H M Highland, J D Stewart, T B Harris, S Trompet, J C Bis, G M Peloso, J A Brody, L Broer, E L Busch, Q Duan, A M Stilp, C J O'Donnell, P W Macfarlane, J S Floyd, J A Kors, H J Lin, R Li-Gao, T Sofer, R Méndez-Giráldez, S R Cummings, S R Heckbert, A Hofman, I Ford, Y Li, L J Launer, K Porthan, C Newton-Cheh, M D Napier, K F Kerr, A P Reiner, K M Rice, J Roach, B M Buckley, E Z Soliman, R de Mutsert, N Sotoodehnia, A G Uitterlinden, K E North, C R Lee, V Gudnason, T Stürmer, F R Rosendaal, K D Taylor, K L Wiggins, J G Wilson, Y-DI Chen, R C Kaplan, K Wilhelmsen, L A Cupples, V Salomaa, C van Duijn, J W Jukema, Y Liu, D O Mook-Kanamori, L A Lange, R S Vasan, A V Smith, B H Stricker, C C Laurie, J I Rotter, E A Whitsel, B M Psaty and C L Avery Pharmacogenomics J 2018 18: 215-226; advance online publication, July 18, 2017; 10.1038/tpj.2017.10 Abstract | Full Text Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy E Abdel-Hady Algharably, J Beige, R Kreutz and J Bolbrinker Pharmacogenomics J 2018 18: 227-231; advance online publication, April 18, 2017; 10.1038/tpj.2017.14 Abstract | Full Text CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction S de Denus, J L Rouleau, D L Mann, G S Huggins, N L Pereira, S H Shah, T P Cappola, R Fouodjio, I Mongrain and M-P Dubé Pharmacogenomics J 2018 18: 232-237; advance online publication, April 25, 2017; 10.1038/tpj.2017.8 Abstract | Full Text Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil R Lacchini, J J Muniz, Y T D A Nobre, A J Cologna, A C P Martins and J E Tanus-Santos Pharmacogenomics J 2018 18: 238-244; advance online publication, April 4, 2017; 10.1038/tpj.2017.2 Abstract | Full Text Evaluating the association of single-nucleotide polymorphisms with tenofovir exposure in a diverse prospective cohort of women living with HIV S M Baxi, R M Greenblatt, P Bacchetti, M Cohen, J A DeHovitz, K Anastos, S J Gange, M A Young and B E Aouizerat and for the Women’s Interagency HIV Study (WIHS) Pharmacogenomics J 2018 18: 245-250; advance online publication, May 2, 2017; 10.1038/tpj.2017.3 Abstract | Full Text Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues A Tourancheau, M Rouleau, S Guauque-Olarte, L Villeneuve, I Gilbert, A Droit and C Guillemette Pharmacogenomics J 2018 18: 251-261; advance online publication, April 25, 2017; 10.1038/tpj.2017.5 Abstract | Full Text Prognostic impact of FOXF1 polymorphisms in gastric cancer patients S Matsusaka, A H Wu, S Cao, D L Hanna, K Chin, D Yang, W Zhang, Y Ning, S Stintzing, A Sebio, Y Sunakawa, S Stremitzer, S Yamauchi, S Okazaki, M D Berger, A Parekh, Y Miyamoto, N Mizunuma and H-J Lenz Pharmacogenomics J 2018 18: 262-269; advance online publication, April 11, 2017; 10.1038/tpj.2017.9 Abstract | Full Text Impact of genetic polymorphisms determining leukocyte/neutrophil count on chemotherapy toxicity S J Glisovic, Y D Pastore, V Gagne, M Plesa, C Laverdière, J M Leclerc, D Sinnett and M Krajinovic Pharmacogenomics J 2018 18: 270-274; advance online publication, May 23, 2017; 10.1038/tpj.2017.16 Abstract | Full Text Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia Y Tanaka, H Nakadate, K Kondoh, K Nakamura, K Koh and A Manabe Pharmacogenomics J 2018 18: 275-280; advance online publication, April 18, 2017; 10.1038/tpj.2017.12 Abstract | Full Text Global genetic variation of select opiate metabolism genes in self-reported healthy individuals F R Wendt, G Pathak, A Sajantila, R Chakraborty and B Budowle Pharmacogenomics J 2018 18: 281-294; advance online publication, April 11, 2017; 10.1038/tpj.2017.13 Abstract | Full Text Role of the UGT2B17 deletion in exemestane pharmacogenetics OPEN S Luo, G Chen, C Truica, C C Baird, K Leitzel and P Lazarus Pharmacogenomics J 2018 18: 295-300; advance online publication, May 23, 2017; 10.1038/tpj.2017.18 Abstract | Full Text Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy J E Megías-Vericat, P Montesinos, M J Herrero, F Moscardó, V Bosó, L Rojas, D Martínez-Cuadrón, R Rodríguez-Veiga, L Sendra, J Cervera, J L Poveda, M Á Sanz and S F Aliño Pharmacogenomics J 2018 18: 301-307; advance online publication, May 9, 2017; 10.1038/tpj.2017.19 Abstract | Full Text On the readiness of physicians for pharmacogenomics testing: an empirical assessment N Amara, J Blouin-Bougie, D Bouthillier and J Simard Pharmacogenomics J 2018 18: 308-318; advance online publication, June 13, 2017; 10.1038/tpj.2017.22 Abstract | Full Text Genetic background influences susceptibility to chemotherapy-induced hematotoxicity D M Gatti, S N Weber, N C Goodwin, F Lammert and G A Churchill Pharmacogenomics J 2018 18: 319-330; advance online publication, June 13, 2017; 10.1038/tpj.2017.23 Abstract | Full Text Urinary Lipidomics: evidence for multiple sources and sexual dimorphism in healthy individuals J Graessler, C S Mehnert, K-M Schulte, S Bergmann, S Strauss, T D Bornstein, J Licinio, M-L Wong, A L Birkenfeld and S R Bornstein Pharmacogenomics J 2018 18: 331-339; advance online publication, June 13, 2017; 10.1038/tpj.2017.24 Abstract | Full Text SNP-based HLA allele tagging, imputation and association with antiepileptic drug-induced cutaneous reactions in Hong Kong Han Chinese H Gui, M Kwok, L Baum, P C Sham, P Kwan and S S Cherny Pharmacogenomics J 2018 18: 340-346; advance online publication, April 11, 2017; 10.1038/tpj.2017.11 Abstract | Full Text Cytochrome P450 interactions are common and consequential in Massachusetts hospital discharges T H McCoy, V M Castro, A Cagan, L Snapper, A Roberson and R H Perlis Pharmacogenomics J 2018 18: 347-350; advance online publication, July 11, 2017; 10.1038/tpj.2017.30 Abstract | Full Text   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.